
Michael Pervan
Examiner (ID: 11308, Phone: (571)272-0910 , Office: P/2621 )
| Most Active Art Unit | 2621 |
| Art Unit(s) | 2693, 2677, 2691, 2629, 2621 |
| Total Applications | 1288 |
| Issued Applications | 1041 |
| Pending Applications | 53 |
| Abandoned Applications | 213 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9517837
[patent_doc_number] => 20140154329
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-05
[patent_title] => 'Process For Stabilizing An Adjuvant Containing Vaccine Composition'
[patent_app_type] => utility
[patent_app_number] => 14/031311
[patent_app_country] => US
[patent_app_date] => 2013-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 11104
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14031311
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/031311 | Process for stabilizing an adjuvant containing vaccine composition | Sep 18, 2013 | Issued |
Array
(
[id] => 9212033
[patent_doc_number] => 20140011210
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-09
[patent_title] => 'ACTINOBACILLUS SUIS ANTIGENS'
[patent_app_type] => utility
[patent_app_number] => 14/027385
[patent_app_country] => US
[patent_app_date] => 2013-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 13844
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14027385
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/027385 | ACTINOBACILLUS SUIS ANTIGENS | Sep 15, 2013 | Abandoned |
Array
(
[id] => 9362721
[patent_doc_number] => 20140072594
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-13
[patent_title] => 'EXPRESSION OF CHIMERIC KSAC PROTEIN AND METHOD OF PRODUCING SOLUBLE PROTEINS BY HIGH PRESSURE'
[patent_app_type] => utility
[patent_app_number] => 14/014437
[patent_app_country] => US
[patent_app_date] => 2013-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 11247
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14014437
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/014437 | Expression of chimeric KSAC protein and method of producing soluble proteins by high pressure | Aug 29, 2013 | Issued |
Array
(
[id] => 9330147
[patent_doc_number] => 20140056929
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-27
[patent_title] => 'IMMUNOMODULATION BY CONTROLLING INTERFERON-GAMMA LEVELS WITH THE LONG NON-CODING RNA NeST'
[patent_app_type] => utility
[patent_app_number] => 13/974981
[patent_app_country] => US
[patent_app_date] => 2013-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 25449
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13974981
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/974981 | IMMUNOMODULATION BY CONTROLLING INTERFERON-GAMMA LEVELS WITH THE LONG NON-CODING RNA NeST | Aug 22, 2013 | Abandoned |
Array
(
[id] => 9670447
[patent_doc_number] => 20140234310
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-21
[patent_title] => 'COMPOSITIONS AND METHODS FOR TREATMENT OF BACTERIAL AND MYCOBACTERIAL INFECTIONS'
[patent_app_type] => utility
[patent_app_number] => 13/958443
[patent_app_country] => US
[patent_app_date] => 2013-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 23467
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13958443
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/958443 | Compositions of, and methods for, alpha-1 anti trypsin Fc fusion molecules | Aug 1, 2013 | Issued |
Array
(
[id] => 9211688
[patent_doc_number] => 20140010865
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-09
[patent_title] => 'ENHANCED IMMUNE RESPONSE IN BOVINE SPECIES'
[patent_app_type] => utility
[patent_app_number] => 13/923496
[patent_app_country] => US
[patent_app_date] => 2013-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 10364
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13923496
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/923496 | ENHANCED IMMUNE RESPONSE IN BOVINE SPECIES | Jun 20, 2013 | Abandoned |
Array
(
[id] => 9222493
[patent_doc_number] => 20140017268
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-16
[patent_title] => 'Composition and Methods for Detecting or Preventing Lawsonia intracellularis Infections'
[patent_app_type] => utility
[patent_app_number] => 13/910861
[patent_app_country] => US
[patent_app_date] => 2013-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 45
[patent_figures_cnt] => 45
[patent_no_of_words] => 31331
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13910861
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/910861 | Composition and Methods for Detecting or Preventing Lawsonia intracellularis Infections | Jun 4, 2013 | Abandoned |
Array
(
[id] => 9995442
[patent_doc_number] => 09040036
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-05-26
[patent_title] => 'Compositions for probiotic recolonisation therapy'
[patent_app_type] => utility
[patent_app_number] => 13/910579
[patent_app_country] => US
[patent_app_date] => 2013-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6018
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13910579
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/910579 | Compositions for probiotic recolonisation therapy | Jun 4, 2013 | Issued |
Array
(
[id] => 10953369
[patent_doc_number] => 20140356391
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-12-04
[patent_title] => 'AMINO ACID SEQUENCES FOR CLINICAL REMISSION OF PSORIASIS AND RELATED DISEASES.'
[patent_app_type] => utility
[patent_app_number] => 13/904440
[patent_app_country] => US
[patent_app_date] => 2013-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13480
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13904440
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/904440 | AMINO ACID SEQUENCES FOR CLINICAL REMISSION OF PSORIASIS AND RELATED DISEASES. | May 28, 2013 | Abandoned |
Array
(
[id] => 10262330
[patent_doc_number] => 20150147328
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-28
[patent_title] => 'VACCINE COMPOSITION FOR PREVENTING STAPHYLLOCOCCUS AUREUS INFECTION'
[patent_app_type] => utility
[patent_app_number] => 14/399225
[patent_app_country] => US
[patent_app_date] => 2013-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8459
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14399225
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/399225 | VACCINE COMPOSITION FOR PREVENTING STAPHYLLOCOCCUS AUREUS INFECTION | May 6, 2013 | Abandoned |
Array
(
[id] => 9134339
[patent_doc_number] => 20130295054
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-07
[patent_title] => 'Modified Bacteria and their Uses thereof for the Treatment of Cancer or Tumor'
[patent_app_type] => utility
[patent_app_number] => 13/871716
[patent_app_country] => US
[patent_app_date] => 2013-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 15330
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13871716
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/871716 | Modified bacteria and their uses thereof for the treatment of cancer or tumor | Apr 25, 2013 | Issued |
Array
(
[id] => 9989141
[patent_doc_number] => 09034339
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-05-19
[patent_title] => 'Nucleic acid and amino acid sequences, and vaccine for the control of ectoparasite infestations in fish'
[patent_app_type] => utility
[patent_app_number] => 13/859314
[patent_app_country] => US
[patent_app_date] => 2013-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 5
[patent_no_of_words] => 7126
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13859314
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/859314 | Nucleic acid and amino acid sequences, and vaccine for the control of ectoparasite infestations in fish | Apr 8, 2013 | Issued |
Array
(
[id] => 9931044
[patent_doc_number] => 20150079236
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-19
[patent_title] => 'LACTOBACILLUS RHAMNOSUS FOOD GRADE BACTERIA'
[patent_app_type] => utility
[patent_app_number] => 14/390018
[patent_app_country] => US
[patent_app_date] => 2013-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6394
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14390018
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/390018 | Lactobacillus rhamnosus food grade bacteria | Apr 4, 2013 | Issued |
Array
(
[id] => 9198214
[patent_doc_number] => 20130337529
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-19
[patent_title] => 'Cell Culture'
[patent_app_type] => utility
[patent_app_number] => 13/857888
[patent_app_country] => US
[patent_app_date] => 2013-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 21963
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13857888
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/857888 | Cell culture | Apr 4, 2013 | Issued |
Array
(
[id] => 10062712
[patent_doc_number] => 09101538
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-08-11
[patent_title] => 'Injectable amino-acid composition'
[patent_app_type] => utility
[patent_app_number] => 13/854955
[patent_app_country] => US
[patent_app_date] => 2013-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 10
[patent_no_of_words] => 3140
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13854955
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/854955 | Injectable amino-acid composition | Mar 31, 2013 | Issued |
Array
(
[id] => 10181585
[patent_doc_number] => 09211248
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-12-15
[patent_title] => 'Compositions and methods for topical application and transdermal delivery of botulinum toxins'
[patent_app_type] => utility
[patent_app_number] => 13/846899
[patent_app_country] => US
[patent_app_date] => 2013-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 13864
[patent_no_of_claims] => 76
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13846899
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/846899 | Compositions and methods for topical application and transdermal delivery of botulinum toxins | Mar 17, 2013 | Issued |
Array
(
[id] => 9212562
[patent_doc_number] => 20140011739
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-09
[patent_title] => 'PROTOZOAN VARIANT-SPECIFIC SURFACE PROTEINS (VSP) AS CARRIERS FOR ORAL DRUG DELIVERY'
[patent_app_type] => utility
[patent_app_number] => 13/843766
[patent_app_country] => US
[patent_app_date] => 2013-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 25905
[patent_no_of_claims] => 60
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13843766
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/843766 | Protozoan variant-specific surface proteins (VSP) as carriers for oral drug delivery | Mar 14, 2013 | Issued |
Array
(
[id] => 9737305
[patent_doc_number] => 20140273022
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-18
[patent_title] => 'BIOMARKERS FOR DETECTING THE PRESENCE OF BACTERIA'
[patent_app_type] => utility
[patent_app_number] => 13/828554
[patent_app_country] => US
[patent_app_date] => 2013-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18149
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13828554
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/828554 | Biomarkers for detecting the presence of bacteria | Mar 13, 2013 | Issued |
Array
(
[id] => 9596772
[patent_doc_number] => 20140193451
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-10
[patent_title] => 'IMMUNOGENIC COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 13/826932
[patent_app_country] => US
[patent_app_date] => 2013-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 26347
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13826932
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/826932 | IMMUNOGENIC COMPOSITION | Mar 13, 2013 | Abandoned |
Array
(
[id] => 10635671
[patent_doc_number] => 09353165
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-05-31
[patent_title] => 'Purification of cell culture derived alpha1 protease inhibitor'
[patent_app_type] => utility
[patent_app_number] => 13/828374
[patent_app_country] => US
[patent_app_date] => 2013-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 7434
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13828374
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/828374 | Purification of cell culture derived alpha1 protease inhibitor | Mar 13, 2013 | Issued |